Minimal Residual Disease Testing Global Market Report 2023

Minimal Residual Disease Testing Global Market Report 2023 – By Test Type (DNA - Based Test, RNA- Based Test, Immunological Test), By Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies), By Application (Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application), By End User (Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic and Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : July 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Minimal Residual Disease Testing Global Market Report 2023

Proud Members Of

Minimal residual disease testing refers to a very sensitive test to detect cancer cells in the patient's body that may remain after treatment. It is used to monitor the effectiveness of cancer treatment and inform future treatment strategies.

The main test types of minimal residual disease testing are DNA - based tests, RNA- based tests, and immunological tests. DNA (deoxyribonucleic acid)-based testing (also known as genetic testing) is a type of medical examination that can spot changes to your chromosomes, genes, or proteins. The various technologies include flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others, are used in various applications such as hematological malignancies, leukemia, lymphoma, solid tumors, and others. These are used by hospitals and specialty clinics, diagnostic laboratories, academic and research institutes, and others.

The global minimal residual disease testing market is segmented -

1) By Test Type: DNA - Based Test, RNA- Based Test, Immunological Test

2) By Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies

3) By Application: Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application

4) By End User: Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic and Research Institutes, Other End Users

The global minimal residual disease testing market size is expected to grow from $1.22 billion in 2022 to $1.41 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global minimal residual disease testing market size is expected to reach $2.32 billion in 2027 at a CAGR of 13.3%.

The increasing prevalence of cancer is expected to propel the growth of the minimal residual disease testing market going forward. Cancer refers to a condition when a few of the body's cells grow out of control and spread to other bodily regions. Cancer stages are primarily detected through minimal residual disease testing, which is a very sensitive method to detect cancer cells in the human body. It helps cancer patients prevent the disease at an early stage, boosting the minimal residual disease testing market. For instance, in February 2022, according to the reports shared by the World Health Organization (WHO), a Switzerland-based health agency, cancer will be the most common cause of death worldwide. In 2020, according to the World Cancer Fund Research International, a UK-based a not-for-profit association related to cancer prevention, there were 18,094,716 million new cases of cancer worldwide. Additionally, in 2020, globally, nearly 10 million people died due to cancer, which is nearly one in six deaths. Therefore, the increasing prevalence of cancer is driving the growth of the minimal residual disease testing market.

Major players in the minimal residual disease testing market are Natera Inc., Guardant Health, Laboratory Corporation of America Holdings, QIAGEN N.V, F. Hoffmann-La Roche Ltd, Bio-Techne Corporation, Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, GRAIL LLC., Veracyte Inc., Cergentis B.V, Mdxhealth, NeoGenomics Laboratories Inc., Adaptive Biotechnologies, OPKO Health Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, and PerkinElmer Inc.

Product innovations are a key trend gaining popularity in the minimal residual disease testing market. Major companies operating in the minimal residual disease testing market are innovating new products to sustain their position in the market. For instance, in 2022, Twist Bioscience, a US-based synthetic biology and genomics company, launched Twist MRD Panel to advance research and development in minimal residual disease (MRD) detection in cancer screening. Twist MRD Panel is a customizable panel of genes that can be used to detect very low levels of residual cancer cells in a patient's blood. The Twist MRD Panel is designed to be highly flexible and customizable that can be integrated into a typical next-generation sequencing (NGS) workflow that can find minimum residual disease (MRD) in just five days.

In August 2021, Illumina Inc., a US-based biotechnology company, acquired GRAIL for $8 billion. With this acquisition, Illumina Inc. fastened its patient access to a life-saving multi-cancer early-detection test and expand its health services at the global level. GRAIL is a US-based biotechnology company that detects cancer at an early stage using the power of next-generation sequencing testing technology and minimal residual disease testing.

North America was the largest region in the minimal residual disease testing market in 2022. The regions covered in the global minimal residual disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the minimal residual disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The minimal residual disease testing market includes revenues earned by entities by providing services such as peripheral blood cell testing, sequencing testing, high-throughput sequencing testing, and methylation sequencing testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The minimal residual disease testing market research report is one of a series of new reports from The Business Research Company that provides minimal residual disease testing market statistics, including minimal residual disease testing industry global market size, regional shares, competitors with a minimal residual disease testing market share, detailed minimal residual disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the minimal residual disease testing industry. This minimal residual disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Minimal Residual Disease Testing Market Characteristics

    3. Minimal Residual Disease Testing Market Trends And Strategies

    4. Minimal Residual Disease Testing Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Minimal Residual Disease Testing Market

    4.2. Ukraine-Russia War Impact On Minimal Residual Disease Testing Market

    4.3. Impact Of High Inflation On Minimal Residual Disease Testing Market

    5. Minimal Residual Disease Testing Market Size And Growth

    5.1. Global Minimal Residual Disease Testing Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Minimal Residual Disease Testing Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Minimal Residual Disease Testing Market Segmentation

    6.1. Global Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    DNA - Based Test

    RNA- Based Test

    Immunological Test

    6.2. Global Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Flow Cytometry

    Polymerase Chain Reaction (PCR)

    Next-Generation Sequencing (NGS)

    Other Technologies

    6.3. Global Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hematological Malignancies

    Leukemia

    Lymphoma

    Solid Tumors

    Other Application

    6.4. Global Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals And Specialty Clinics

    Diagnostic Laboratories

    Academic and Research Institutes

    Other End Users

    7. Minimal Residual Disease Testing Market Regional And Country Analysis

    7.1. Global Minimal Residual Disease Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Minimal Residual Disease Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Minimal Residual Disease Testing Market

    8.1. Asia-Pacific Minimal Residual Disease Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Minimal Residual Disease Testing Market

    9.1. China Minimal Residual Disease Testing Market Overview

    9.2. China Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Minimal Residual Disease Testing Market

    10.1. India Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Minimal Residual Disease Testing Market

    11.1. Japan Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Minimal Residual Disease Testing Market

    12.1. Australia Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Minimal Residual Disease Testing Market

    13.1. Indonesia Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Minimal Residual Disease Testing Market

    14.1. South Korea Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Minimal Residual Disease Testing Market

    15.1. Western Europe Minimal Residual Disease Testing Market Overview

    15.2. Western Europe Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Minimal Residual Disease Testing Market

    16.1. UK Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Minimal Residual Disease Testing Market

    17.1. Germany Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Minimal Residual Disease Testing Market

    18.4. France Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Minimal Residual Disease Testing Market

    19.1. Eastern Europe Minimal Residual Disease Testing Market Overview

    19.2. Eastern Europe Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Minimal Residual Disease Testing Market

    20.1. Russia Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Minimal Residual Disease Testing Market

    21.1. North America Minimal Residual Disease Testing Market Overview

    21.2. North America Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Minimal Residual Disease Testing Market

    22.1. USA Minimal Residual Disease Testing Market Overview

    22.2. USA Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Minimal Residual Disease Testing Market

    23.1. South America Minimal Residual Disease Testing Market Overview

    23.2. South America Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Minimal Residual Disease Testing Market

    24.1. Brazil Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Minimal Residual Disease Testing Market

    25.1. Middle East Minimal Residual Disease Testing Market Overview

    25.2. Middle East Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Minimal Residual Disease Testing Market

    26.1. Africa Minimal Residual Disease Testing Market Overview

    26.2. Africa Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Minimal Residual Disease Testing Market Competitive Landscape And Company Profiles

    27.1. Minimal Residual Disease Testing Market Competitive Landscape

    27.2. Minimal Residual Disease Testing Market Company Profiles

    27.2.1. Natera Inc.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Guardant Health

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Laboratory Corporation of America Holdings

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. QIAGEN N.V

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. F. Hoffmann-La Roche Ltd

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Minimal Residual Disease Testing Market

    29. Minimal Residual Disease Testing Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Minimal Residual Disease Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Minimal Residual Disease Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Natera Inc. Financial Performance
  • Table 48: Guardant Health Financial Performance
  • Table 49: Laboratory Corporation of America Holdings Financial Performance
  • Table 50: QIAGEN N.V Financial Performance
  • Table 51: F. Hoffmann-La Roche Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Minimal Residual Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Minimal Residual Disease Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Minimal Residual Disease Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Minimal Residual Disease Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Minimal Residual Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Minimal Residual Disease Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Natera Inc. Financial Performance
  • Figure 48: Guardant Health Financial Performance
  • Figure 49: Laboratory Corporation of America Holdings Financial Performance
  • Figure 50: QIAGEN N.V Financial Performance
  • Figure 51: F. Hoffmann-La Roche Ltd Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report